Back to top
See More Zacks Research for These Tickers
Normally $25 each - click below to receive one report FREE:
GSK PLC Sponsored ADR (GSK) - free report >>
BlackRock, Inc. (BLK) - free report >>
We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies, revised Privacy Policy and Terms of Service.
You are being directed to ZacksTrade, a division of LBMZ Securities and licensed broker-dealer. ZacksTrade and Zacks.com are separate companies. The web link between the two companies is not a solicitation or offer to invest in a particular security or type of security. ZacksTrade does not endorse or adopt any particular investment strategy, any analyst opinion/rating/report or any approach to evaluating individual securities.
If you wish to go to ZacksTrade, click OK. If you do not, click Cancel.
GSK PLC Sponsored ADR (GSK) - free report >>
BlackRock, Inc. (BLK) - free report >>
Image: Bigstock
New Strong Sell Stocks for January 11th
Here are 5 stocks added to the Zacks Rank #5 (Strong Sell) List today:
Anadarko Petroleum Corporation is involved in exploration, development, production and marketing of oil and gas. The Zacks Consensus Estimate for its current year earnings has been revised 10.3% downward over the last 60 days.
BlackRock, Inc. (BLK - Free Report) is a provider of investment management services. The Zacks Consensus Estimate for its current year earnings has been revised 0.5% downward over the last 60 days.
Cleveland-Cliffs Inc. (CLF - Free Report) is the owner and operator of an iron ore mining company. The Zacks Consensus Estimate for its current year earnings has been revised 1.3% downward over the last 30 days.
Diamondback Energy, Inc. (FANG - Free Report) is engaged in acquisition, development, exploration, and exploitation of onshore oil and natural gas reserves. The Zacks Consensus Estimate for its current year earnings has been revised 1.5% downward over the last 60 days.
GlaxoSmithKline plc (GSK - Free Report) is engaged in the creation, discovery, development, manufacture and marketing of vaccines and other medicines. The Zacks Consensus Estimate for its current year earnings has been revised 0.3% downward over the last 60 days.
View the entire Zacks Rank #5 List.